2-(5,6,7,8-Tetrahydronaphthalen-2-yloxy)acetic acid, 97%, 50mg

N,N,N',N'',N''-Pentakis(2-hydroxypropyl)diethylenetriamine>95.0%(T)25g

ethyl 2-amino-5-benzylthiophene-3-carboxylate, 95.0%, 250mg

2-(DIFLUOROMETHYL)PYRIDINE-4-CARBONITRILE, 95.0%, 250mg

2-Hydroxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one, 98%, 1g

3-(isobutyrylamino)-4-methylbenzoic acid, 95.0%, 5g

Thalidomide-O-amido-PEG-C2-NH2 (hydrochloride), 25mg

4-(ethoxymethyl)piperidine hydrochloride, 95.0%, 1g

4-(Trifluoromethyl)cinnamic acid, 98.0%, 1g

butyl[(2E)-3-(4-methoxyphenyl)prop-2-en-1-yl]amine hydrochloride, 95.0%, 10g

Quinuclidine>96.0%(GC)(T)1g

Labels on DIN A4 sheets Paper with impregnation, 50.8 x 70 mm, 30 pieces

2,6-Diphenylanthracene (purified by sublimation)>98.0%(GC)100mg